Medicare, Medicaid, and CLIA programs; extension of certain effective dates for clinical laboratory requirements under CLIA.  Centers for Disease Control and Prevention (CDC) and Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
This final rule extends certain effective dates for clinical laboratory requirements in regulations published on February 28, 1992, that implemented provisions of the Clinical Laboratory Improvement Amendments of 1988 (CLIA).  This rule extends the phase-in date of the quality control requirements applicable to moderate and high complexity tests and extends the date by which an individual with a doctoral degree must possess board certification to qualify as a director of a laboratory that performs high complexity testing. These effective dates are extended to allow the Department to revise quality control requirements and establish the qualification requirements necessary for individuals with doctoral degrees to serve as directors of laboratories performing high complexity testing.  These effective date extensions do not reduce the current requirements for quality test performance.
D000288:Administrative Personnel / Q000331:legislation & jurisprudence / Q000592:standards; D003406:Credentialing / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D008484:Medicaid; D017056:Medical Laboratory Personnel / Q000331:legislation & jurisprudence / Q000592:standards; D006278:Medicare; D014481:United States